Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study
Jazyk angličtina Země Spojené státy americké Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
R01 MH059556
NIMH NIH HHS - United States
R01 MH059535
NIMH NIH HHS - United States
R01 MH059567
NIMH NIH HHS - United States
R01 MH059545
NIMH NIH HHS - United States
P01 CA089392
NCI NIH HHS - United States
Z01 MH002810
Intramural NIH HHS - United States
I01 BX003431
BLRD VA - United States
R01 MH059548
NIMH NIH HHS - United States
R01 MH059533
NIMH NIH HHS - United States
U01 MH092758
NIMH NIH HHS - United States
K02 DA021237
NIDA NIH HHS - United States
R01 MH059553
NIMH NIH HHS - United States
R01 MH060068
NIMH NIH HHS - United States
MR/L006642/1
Medical Research Council - United Kingdom
R01 MH059534
NIMH NIH HHS - United States
PubMed
38395906
PubMed Central
PMC10891068
DOI
10.1038/s41398-024-02811-4
PII: 10.1038/s41398-024-02811-4
Knihovny.cz E-zdroje
- MeSH
- bipolární porucha * farmakoterapie genetika MeSH
- celogenomová asociační studie MeSH
- fokální adheze MeSH
- fosfatidylinositol-3-kinasy genetika MeSH
- lidé MeSH
- lithium * farmakologie terapeutické užití MeSH
- multiomika MeSH
- protoonkogenní proteiny c-akt genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- fosfatidylinositol-3-kinasy MeSH
- lithium * MeSH
- protoonkogenní proteiny c-akt MeSH
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD.
Bipolar Center Wiener Neustadt Austria
Campus for Ageing and Vitality Newcastle University Newcastle upon Tyne UK
Child and Adolescent Psychiatry Research Center Stockholm Sweden
CIBER de Salud Mental ISCIII Madrid Barcelona Catalonia Spain
Department of Adult Psychiatry Poznan University of Medical Sciences Poznan Poland
Department of Biomedical Sciences University of Cagliari Cagliari Italy
Department of Biomedicine Aarhus University Aarhus Denmark
Department of Clinical Neurosciences Karolinska Institutet Stockholm Sweden
Department of Health Sciences Research Mayo Clinic Rochester MN USA
Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden
Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy
Department of Mental Health Johns Hopkins Bloomberg School of Public Health Baltimore MD USA
Department of Pharmacology Dalhousie University Halifax NS Canada
Department of Pharmacy VA San Diego Healthcare System La Jolla CA USA
Department of Psychiatry and Behavioral Sciences Johns Hopkins University Baltimore MD USA
Department of Psychiatry and Psychology Mayo Clinic Rochester MN USA
Department of Psychiatry Dalhousie University Halifax NS Canada
Department of Psychiatry Dokkyo Medical University School of Medicine Mibu Japan
Department of Psychiatry Hokkaido University Graduate School of Medicine Sapporo Japan
Department of Psychiatry Lindner Center of Hope University of Cincinnati Mason OH USA
Department of Psychiatry Massachusetts General Hospital and Harvard Medical School Boston MA USA
Department of Psychiatry Nagoya University Graduate School of Medicine Nagoya Japan
Department of Psychiatry University of Antioquia Medellín Medellín Colombia
Department of Psychiatry University of Calgary Calgary AB Canada
Department of Psychiatry University of California San Diego La Jolla CA USA
Department of Psychiatry University of Campinas Campinas Brazil
Department of Psychiatry University of Iowa Iowa City IA USA
Department of Psychiatry University of Münster Münster Germany
Department of Psychiatry University of Naples SUN Naples Italy
Department of Psychiatry University of Toronto Toronto ON Canada
Department of Psychiatry VA San Diego Healthcare System La Jolla CA USA
Discipline of Psychiatry University of Adelaide Adelaide SA Australia
Douglas Mental Health University Institute McGill University Montreal QC Canada
Fliedner Klinik Berlin Center for Psychiatry Psychotherapy and Psychosomatic Medicine Berlin Germany
Human Genomics Research Group Department of Biomedicine University Hospital Basel Basel Switzerland
Inserm U955 Psychiatrie Translationnelle Créteil France
Institute of Epidemiology and Preventive Medicine National Taiwan University Taipei Taiwan
Laboratory for Molecular Dynamics of Mental Disorders RIKEN Brain Science Institute Saitama Japan
Ludwig Maximilians University of Munich Munich Germany
Mental Illness Research Theme Neuroscience Research Australia Sydney NSW Australia
Montreal Neurological Institute and Hospital McGill University Montreal QC Canada
Mood Disorders Center of Ottawa Ottawa ON Canada
National Institute of Mental Health Klecany Czech Republic
Neurosciences Section Department of Medicine and Surgery University of Salerno Salerno Italy
Pôle de Psychiatrie Générale Universitaire Centre Hospitalier Charles Perrens Bordeaux France
Psychiatric Genetic Unit Poznan University of Medical Sciences Poznan Poland
School of Medical Sciences University of New South Wales Sydney NSW Australia
School of Psychiatry University of New South Wales and Black Dog Institute Sydney NSW Australia
The Neuromodulation Unit McGill University Health Centre Montreal QC Canada
The University of Queensland Queensland Brain Institute Brisbane QLD Australia
Unit of Clinical Pharmacology Hospital University Agency of Cagliari Cagliari Italy
Veterans Administration San Diego Healthcare System San Diego CA USA
Zobrazit více v PubMed
Dome P, Rihmer Z, Gonda X. Suicide risk in bipolar disorder: a brief review. Medicina. 2019;55. 10.3390/medicina55080403. PubMed PMC
Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646. doi: 10.1136/bmj.f3646. PubMed DOI
Plans L, Barrot C, Nieto E, Rios J, Schulze TG, Papiol S, et al. Association between completed suicide and bipolar disorder: a systematic review of the literature. J Affect Disord. 2019;242:111–22. doi: 10.1016/j.jad.2018.08.054. PubMed DOI
Sajatovic M. Bipolar disorder: disease burden. Am J Manag Care. 2005;11:S80–4. PubMed
Rybakowski JK. Lithium. Eur Neuropsychopharmacol. 2022;57:86–7. doi: 10.1016/j.euroneuro.2022.01.111. PubMed DOI
Kato T. Mechanisms of action of anti-bipolar drugs. Eur Neuropsychopharmacol. 2022;59:23–5. doi: 10.1016/j.euroneuro.2022.03.008. PubMed DOI
Machado-Vieira R, Manji HK, Zarate CA., Jr The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009;11(Suppl 2):92–109. doi: 10.1111/j.1399-5618.2009.00714.x. PubMed DOI PMC
Freland L, Beaulieu J-M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci. 2012;5:14. doi: 10.3389/fnmol.2012.00014. PubMed DOI PMC
Jope RS. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharm Sci. 2003;24:441–3. doi: 10.1016/S0165-6147(03)00206-2. PubMed DOI
Mishra HK, Wei H, Rohr KE, Ko I, Nievergelt CM, Maihofer AX, et al. Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder. Eur Neuropsychopharmacol. 2023;74:1–14. doi: 10.1016/j.euroneuro.2023.04.009. PubMed DOI PMC
Hermida MA, Dinesh Kumar J, Leslie NR. GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Adv Biol Regul. 2017;65:5–15. doi: 10.1016/j.jbior.2017.06.003. PubMed DOI
Watson DG, Lenox RH. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem. 1996;67:767–77. doi: 10.1046/j.1471-4159.1996.67020767.x. PubMed DOI
Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao W-N, et al. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Proc Natl Acad Sci USA. 2017;114:E4462–71. doi: 10.1073/pnas.1700111114. PubMed DOI PMC
Zhao W-N, Tobe BTD, Udeshi ND, Xuan LL, Pernia CD, Zolg DP, et al. Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion. Transl Psychiatry. 2020;10:76. doi: 10.1038/s41398-020-0753-6. PubMed DOI PMC
Amare AT, Thalamuthu A, Schubert KO, Fullerton JM, Ahmed M, Hartmann S, et al. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder. Mol Psychiatry. 2023. 10.1038/s41380-023-02149-1. PubMed PMC
Papiol S, Schulze TG, Heilbronner U. Lithium response in bipolar disorder: genetics, genomics, and beyond. Neurosci Lett. 2022;785:136786. doi: 10.1016/j.neulet.2022.136786. PubMed DOI
Mertens J, Wang Q-W, Kim Y, Yu DX, Pham S, Yang B, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015;527:95–9. doi: 10.1038/nature15526. PubMed DOI PMC
Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002;63:942–7. doi: 10.4088/JCP.v63n1013. PubMed DOI
Cruceanu C, Alda M, Turecki G. Lithium: a key to the genetics of bipolar disorder. Genome Med. 2009;1:79. doi: 10.1186/gm79. PubMed DOI PMC
Leiserson MDM, Eldridge JV, Ramachandran S, Raphael BJ. Network analysis of GWAS data. Curr Opin Genet Dev. 2013;23:602–10. doi: 10.1016/j.gde.2013.09.003. PubMed DOI PMC
Carlin DE, Fong SH, Qin Y, Jia T, Huang JK, Bao B, et al. A fast and flexible framework for network-assisted genomic association. iScience. 2019;16:155–61. doi: 10.1016/j.isci.2019.05.025. PubMed DOI PMC
Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, et al. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry. 2016;16:129. doi: 10.1186/s12888-016-0732-x. PubMed DOI PMC
Niemsiri V, Rosenthal SB, Nievergelt CM, Maihofer AX, Marchetto MC, Santos R, et al. Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis. Mol Psychiatry. 2023 doi: 10.1038/s41380-022-01909-9. PubMed DOI PMC
Short CA, Suarez-Zayas EA, Gomez TM. Cell adhesion and invasion mechanisms that guide developing axons. Curr Opin Neurobiol. 2016;39:77–85. doi: 10.1016/j.conb.2016.04.012. PubMed DOI PMC
Maletic V, Raison C. Integrated neurobiology of bipolar disorder. Front Psychiatry. 2014;5:98. doi: 10.3389/fpsyt.2014.00098. PubMed DOI PMC
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387:1085–93. doi: 10.1016/S0140-6736(16)00143-4. PubMed DOI PMC
Sollis E, Mosaku A, Abid A, Buniello A, Cerezo M, Gil L, et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 2023;51:D977–85. doi: 10.1093/nar/gkac1010. PubMed DOI PMC
Manchia M, Adli M, Akula N, Ardau R, Aubry J-M, Backlund L, et al. Assessment of response to lithium maintenance treatment in bipolar disorder: a Consortium on Lithium Genetics (ConLiGen) Report. PLoS ONE. 2013;8:e65636. doi: 10.1371/journal.pone.0065636. PubMed DOI PMC
Marie-Claire C, Courtin C, Bellivier F, Scott J, Etain B. Methylomic biomarkers of lithium response in bipolar disorder: a proof of transferability study. Pharmaceuticals. 2022;15. 10.3390/ph15020133. PubMed PMC
Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826. doi: 10.1038/s41467-017-01261-5. PubMed DOI PMC
Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–46. doi: 10.1093/nar/gkac1000. PubMed DOI PMC
Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–12. doi: 10.1093/nar/gkaa1074. PubMed DOI PMC
Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27. PubMed DOI PMC
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504. doi: 10.1101/gr.1239303. PubMed DOI PMC
Wu C. Focal adhesion: a focal point in current cell biology and molecular medicine. Cell Adh Migr. 2007;1:13–8. PubMed PMC
Omotade OF, Pollitt SL, Zheng JQ. Actin-based growth cone motility and guidance. Mol Cell Neurosci. 2017;84:4–10. doi: 10.1016/j.mcn.2017.03.001. PubMed DOI PMC
Williams RSB, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature. 2002;417:292–5. doi: 10.1038/417292a. PubMed DOI
Shah SM, Patel CH, Feng AS, Kollmar R. Lithium alters the morphology of neurites regenerating from cultured adult spiral ganglion neurons. Hear Res. 2013;304:137–44. doi: 10.1016/j.heares.2013.07.001. PubMed DOI PMC
Owen R, Gordon-Weeks PR. Inhibition of glycogen synthase kinase 3β in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones. Mol Cell Neurosci. 2003;23:626–37. doi: 10.1016/S1044-7431(03)00095-2. PubMed DOI
Murase S. Impaired focal adhesion kinase-Grb2 interaction during elevated activity in hippocampal neurons. Int J Mol Sci. 2015;16:15659–69. doi: 10.3390/ijms160715659. PubMed DOI PMC
Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, Grinberg LT, et al. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol. 2011;14:1075–89. doi: 10.1017/S146114571000146X. PubMed DOI
Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons in bipolar disorder. Arch Gen Psychiatry. 2011;68:340–50. doi: 10.1001/archgenpsychiatry.2010.175. PubMed DOI PMC
Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 2002;4:105–16. doi: 10.1034/j.1399-5618.2002.01149.x. PubMed DOI
Mohamadian M, Fallah H, Ghofrani-Jahromi Z, Rahimi-Danesh M, Shokouhi Qare Saadlou M-S, Vaseghi S. Mood and behavior regulation: interaction of lithium and dopaminergic system. Naunyn Schmiedebergs Arch Pharmacol. 2023. 10.1007/s00210-023-02437-1. PubMed
Talari K, Goyal M. Retrospective studies—utility and caveats. J R Coll Physicians Edinb. 2020;50:398–402. doi: 10.4997/jrcpe.2020.409. PubMed DOI